CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Celltrion, Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2023-00533 filed by Celltrion, Inc. et al. on 2023-02-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00533

Filing Date

2023-02-10

Accorded Filing Date

2023-02-10

Institution Decision Date

2023-03-22

Last Modified Date

2024-08-23

Proceeding Type

IPR

Termination Date

2024-01-09

Trial Status

Final Written Decision

Parties & Counsel

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved
Respondent Application Number 16397267
Respondent Patent Number 10888601
Respondent Inventor George D. YANCOPOULOS
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)
Customer Number 191459
Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
41408 David Marsh 202-942-5068
48001 Thomas Triolo 914-847-1612
48921 Stephen Gaudet 914-847-7376
50370 Neil Miyamoto 914-847-7175
50437 Frank Cottingham 914-593-1116
58583 Brian Cocca 914-847-1421
58714 Ilona Gont 914-847-1304
59668 Brandon Schurter 914-847-7000

Proceeding Documents

114
11

Other: Fed Circuit mandate OTHER

2024-08-23 FILING PARTY: BOARD
10

Final Written Decision: original FINAL

2024-01-09 FILING PARTY: BOARD
8

Petitioner's Updated Power of Attorney NOTICE

2023-04-28 FILING PARTY: PETITIONER
9

Petitioner's Updated Mandatory Notice NOTICE

2023-04-28 FILING PARTY: PETITIONER
3001

Ex. 3001 Exhibit

2023-03-22 FILING PARTY: BOARD